Pricing Log in Create free account

Medpace Holdings, Inc. (MEDP) vs Revvity Inc. (RVTY)

Medpace Holdings, Inc. and Revvity Inc. are both Diagnostics & Research companies. Medpace Holdings, Inc. and Revvity Inc. are of similar size ($17.8B and $16.8B). Medpace Holdings, Inc. trades at the lower P/E: 34.6× against 71.9×. Medpace Holdings, Inc. grew revenue faster over the last twelve months: 20.4% against 4.56%. Medpace Holdings, Inc. has the higher net margin (18.2% vs 8.61%) and the lower return on invested capital (0.00% vs 2.50%). Across the 22 metrics below, Medpace Holdings, Inc. leads on 17 and Revvity Inc. on 5.

Valuation

Metric MEDP RVTY Diagnostics & Research median
P/E 34.57 71.89 34.52
P/S 6.25 5.73 4.24
P/B 30.31 2.33 3.42
Price to free cash flow 26.56 28.19 33.51
EV/EBITDA 27.01 25.08 23.44
EV/Sales 6.04 6.61 5.18
Earnings yield 2.89% 1.39% (1.50%)
Free cash flow yield 3.77% 3.55% 0.00%

Profitability

Metric MEDP RVTY Diagnostics & Research median
Gross margin 72.24% 55.91% 48.32%
Operating margin 21.39% 12.65% (5.68%)
Net margin 18.24% 8.61% (4.10%)
Free cash flow margin 23.52% 20.48% 0.00%
Return on equity 117.88% 0.00% 0.00%
Return on assets 25.54% 2.14% (6.05%)
Return on invested capital 0.00% 2.50% 0.00%

Growth

Metric MEDP RVTY Diagnostics & Research median
Revenue growth (TTM) 20.35% 4.56% 8.99%
EPS growth (last fiscal year) 20.98% (5.91%) 20.36%
Revenue growth, 5-year CAGR 22.27% 1.41% 7.30%
Net income growth, 5-year CAGR 25.50% (19.82%) 0.00%

Health

Metric MEDP RVTY Diagnostics & Research median
Debt to equity 0.00 0.36 0.01
Current ratio 0.83 2.65 2.27
Net debt to EBITDA (0.88) 3.00 0.68

Dividend

Metric MEDP RVTY Diagnostics & Research median
Dividend yield — 0.19% 0.67%
Payout ratio — 0.12 0.20

Size

Metric MEDP RVTY Diagnostics & Research median
Market cap 17.76b 16.83b 2.22b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack